Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Helen K. Ellias Insider Profile
4 Followers
Helen K. Ellias, Director at SAB Biotherapeutics, holds 2.86M shares in SAB Biotherapeutics (Ticker: SABS).
Helen K. Ellias has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Helen K. Ellias's holdings
Insider Roles
Director
Roles that Helen K. Ellias holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Helen K. Ellias
Helen K. Ellias's Trading History
List of latest transactions for each holding click on a transaction to see Helen K. Ellias's performance on stock
You May Also Like
Helen K. Ellias insider profile FAQ
What is the percentage of profitable transactions made by Helen K. Ellias?
The percentage of profitable transactions made by Helen K. Ellias is ―.
What is the average return per transaction made by Helen K. Ellias?
The average return per transaction made by Helen K. Ellias is ―.
What stocks does Helen K. Ellias hold?
Helen K. Ellias holds: SABS stocks.
What was Helen K. Ellias’s latest transaction?
Helen K. Ellias latest transaction was an Uninformative Buy of $1.80M.
What was Helen K. Ellias's most profitable transaction?
Helen K. Ellias’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Helen K. Ellias's role in SAB Biotherapeutics?
Helen K. Ellias's role in SAB Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.